BCR and Autoimmunity: A better understanding of how BCR recognition of antigen is tuned to control downstream processes and outcomes of B cell activation will require additional BCR animal models with homogeneous B cell populations; these models will enhance our knowledge for the rational design of therapies aimed to boost B cell responses or control B cell malignancies and autoimmunity.